Lung Transplant Improves Survival and Quality of Life Regardless of Telomere Dysfunction
Introduction: Fibrotic interstitial lung diseases (ILDs) are the first indication for lung transplantation (LT). Telomere dysfunction has been associated with poor post-transplant outcomes. The aim of the study was to evaluate the morbi-mortality and quality of life in fibrotic ILDs after lung transplant depending on telomere biology.Methods: Fibrotic ILD patients that underwent lung transplant were allocated to two arms; with or without telomere dysfunction at diagnosis based on the telomere length and telomerase related gene mutations revealed by whole-exome sequencing. Post-transplant evaluation included: (1) short and long-term mortality and complications and (2) quality of life.Results: Fifty-five percent of patients that underwent LT carried rare coding mutations in telomerase-related genes. Patients with telomere shortening more frequently needed extracorporeal circulation and presented a higher rate of early post-transplant hematological complications, longer stay in the intensive care unit (ICU), and a higher number of long-term hospital admissions. However, post-transplant 1-year survival was higher than 80% regardless of telomere dysfunction, with improvement in the quality of life and oxygen therapy withdrawal.Conclusions: Post-transplant morbidity is higher in patients with telomere dysfunction and differs according to elapsed time from transplantation. However, lung transplant improves survival and quality of life and the associated complications are manageable..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
Frontiers in Medicine - 8(2021) |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lurdes Planas-Cerezales [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Genetics |
|---|
| doi: |
10.3389/fmed.2021.695919 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ020103735 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ020103735 | ||
| 003 | DE-627 | ||
| 005 | 20230501194405.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fmed.2021.695919 |2 doi | |
| 035 | |a (DE-627)DOAJ020103735 | ||
| 035 | |a (DE-599)DOAJ3484fc4faf5b46df941de8cb1fb950bd | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a R5-920 | |
| 100 | 0 | |a Lurdes Planas-Cerezales |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Lung Transplant Improves Survival and Quality of Life Regardless of Telomere Dysfunction |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Introduction: Fibrotic interstitial lung diseases (ILDs) are the first indication for lung transplantation (LT). Telomere dysfunction has been associated with poor post-transplant outcomes. The aim of the study was to evaluate the morbi-mortality and quality of life in fibrotic ILDs after lung transplant depending on telomere biology.Methods: Fibrotic ILD patients that underwent lung transplant were allocated to two arms; with or without telomere dysfunction at diagnosis based on the telomere length and telomerase related gene mutations revealed by whole-exome sequencing. Post-transplant evaluation included: (1) short and long-term mortality and complications and (2) quality of life.Results: Fifty-five percent of patients that underwent LT carried rare coding mutations in telomerase-related genes. Patients with telomere shortening more frequently needed extracorporeal circulation and presented a higher rate of early post-transplant hematological complications, longer stay in the intensive care unit (ICU), and a higher number of long-term hospital admissions. However, post-transplant 1-year survival was higher than 80% regardless of telomere dysfunction, with improvement in the quality of life and oxygen therapy withdrawal.Conclusions: Post-transplant morbidity is higher in patients with telomere dysfunction and differs according to elapsed time from transplantation. However, lung transplant improves survival and quality of life and the associated complications are manageable. | ||
| 650 | 4 | |a interstitial lung disease | |
| 650 | 4 | |a pulmonary fibrosis | |
| 650 | 4 | |a genetics | |
| 650 | 4 | |a telomere shortening | |
| 650 | 4 | |a telomere disorders | |
| 650 | 4 | |a lung transplantation | |
| 653 | 0 | |a Medicine (General) | |
| 700 | 0 | |a Elena G. Arias-Salgado |e verfasserin |4 aut | |
| 700 | 0 | |a Elena G. Arias-Salgado |e verfasserin |4 aut | |
| 700 | 0 | |a Cristina Berastegui |e verfasserin |4 aut | |
| 700 | 0 | |a Ana Montes-Worboys |e verfasserin |4 aut | |
| 700 | 0 | |a Rafaela González-Montelongo |e verfasserin |4 aut | |
| 700 | 0 | |a José. M. Lorenzo-Salazar |e verfasserin |4 aut | |
| 700 | 0 | |a Vanesa Vicens-Zygmunt |e verfasserin |4 aut | |
| 700 | 0 | |a Marta Garcia-Moyano |e verfasserin |4 aut | |
| 700 | 0 | |a Jordi Dorca |e verfasserin |4 aut | |
| 700 | 0 | |a Carlos Flores |e verfasserin |4 aut | |
| 700 | 0 | |a Carlos Flores |e verfasserin |4 aut | |
| 700 | 0 | |a Carlos Flores |e verfasserin |4 aut | |
| 700 | 0 | |a Carlos Flores |e verfasserin |4 aut | |
| 700 | 0 | |a Rosario Perona |e verfasserin |4 aut | |
| 700 | 0 | |a Rosario Perona |e verfasserin |4 aut | |
| 700 | 0 | |a Antonio Román |e verfasserin |4 aut | |
| 700 | 0 | |a María Molina-Molina |e verfasserin |4 aut | |
| 700 | 0 | |a María Molina-Molina |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Frontiers in Medicine |d Frontiers Media S.A., 2014 |g 8(2021) |w (DE-627)DOAJ000022292 |x 2296858X |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2021 |
| 856 | 4 | 0 | |u https://doi.org/10.3389/fmed.2021.695919 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/3484fc4faf5b46df941de8cb1fb950bd |z kostenfrei |
| 856 | 4 | 0 | |u https://www.frontiersin.org/articles/10.3389/fmed.2021.695919/full |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2296-858X |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2021 | ||